The purpose of this study is to compare clinical outcomes in the treatment of deep non-contained intrabony defects ( i.e. , with @ % @-wall component and a residual @ - to @-wall component in the most apical part ) using deproteinized bovine bone mineral ( DBBM ) combined with either enamel matrix protein derivative ( EMD ) or collagen membrane ( CM ) .